From May 11, 2022 to June 30, 2022, the company has repurchased 194,900 shares, representing 0.44% for ¥400.29 million. With this, the company has completed the repurchase of 194,900 shares, representing 0.44% for ¥400.29 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,961 JPY | +0.05% | -2.00% | -2.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.78% | 551M | |
+16.31% | 42.32B | |
+16.32% | 21.29B | |
+19.33% | 15.29B | |
+18.71% | 14.36B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-12.24% | 6.58B | |
-8.87% | 5.73B | |
+11.64% | 5.51B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.